What is LOPJLB’s current signal on HLVX?

LOPJLB’s latest quantitative signal on HilleVax, Inc. (HLVX) is BUY in a BULL regime. Signals are updated daily.

What market regime is HLVX in?

HilleVax, Inc. (HLVX) is currently classified in the BULL HMM market regime on LOPJLB.

What does HilleVax, Inc. (HLVX) do?

HilleVax, Inc. is a clinical-stage biopharmaceutical enterprise specializing in the creation and market introduction of innovative vaccines. The company's lead investigational product is HIL-214, a vaccine candidate utilizing virus-like particles, which aims to prevent moderate-to-severe acute gastroenteritis resulting from norovirus infections. Its corporate headquarters are located in Boston,…

HilleVax, Inc. (HLVX)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$2.09+0.00%Close

BUYBULL · day 18

[SCORES & PROFILE]

FUND: 17
VALUE: 30
GROWTH: 45
GARP: 6
TYPE: Value / Recovery (blended)

Composite of Value · Growth · GARP

ROIC-42.1%

REV YoY-

ROE-70.1%

EPS YoY-

ROA-76.4%

GROSS

NET

[VALUATION]

P/E TTM-0.70

P/E FWD-

SECTOR PE20.34

INDUSTRY PE13.84

P/B0.66

P/FCF-

EV/EBITDA0.16

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E15.87

ALTMAN Z-

CURR RATIO10.84

ND/EBITDA-

BETA0.77

FAQ

What is LOPJLB’s current signal on HLVX?: LOPJLB’s latest quantitative signal on HilleVax, Inc. (HLVX) is BUY in a BULL regime. Signals are updated daily.
What market regime is HLVX in?: HilleVax, Inc. (HLVX) is currently classified in the BULL HMM market regime on LOPJLB.
What does HilleVax, Inc. (HLVX) do?: HilleVax, Inc. is a clinical-stage biopharmaceutical enterprise specializing in the creation and market introduction of innovative vaccines. The company's lead investigational product is HIL-214, a vaccine candidate utilizing virus-like particles, which aims to prevent moderate-to-severe acute gastroenteritis resulting from norovirus infections. Its corporate headquarters are located in Boston,…

HilleVax, Inc. (HLVX)

Key stats

Prediction markets

FUNDAMENTALS

Company news

FAQ